Les Sulewski
Stock Analyst at Truist Financial
(4.02)
# 1,762
Out of 4,707 analysts
185
Total ratings
52.3%
Success rate
9.3%
Average return
Main Sectors:
Stocks Rated by Les Sulewski
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRMD CorMedix | Maintained: Buy | n/a | $8.18 | - | 23 | May 15, 2026 | |
| COLL Collegium Pharmaceutical | Maintained: Buy | n/a | $23.37 | - | 20 | May 14, 2026 | |
| ANIP ANI Pharmaceuticals | Maintained: Hold | n/a | $70.23 | - | 25 | May 11, 2026 | |
| VTRS Viatris | Reiterated: Buy | $20 | $16.61 | +20.41% | 8 | May 8, 2026 | |
| VNDA Vanda Pharmaceuticals | Maintained: Buy | $18 | $5.33 | +237.71% | 4 | May 7, 2026 | |
| PCRX Pacira BioSciences | Maintained: Buy | n/a | $25.87 | - | 24 | May 1, 2026 | |
| TSX: BHC Bausch Health Companies Inc. | Reiterated: Hold | n/a | $8.86 | - | 18 | May 1, 2026 | |
| TEVA Teva Pharmaceutical Industries | Rated: Buy | $42 → $45 | $36.76 | +22.42% | 11 | Apr 30, 2026 | |
| AMRX Amneal Pharmaceuticals | Maintained: Buy | n/a | $17.05 | - | 21 | Apr 23, 2026 | |
| BTMD biote | Maintained: Buy | $5 → $4 | $1.51 | +164.90% | 19 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | €22.00 | €22.60 | n/a | 1 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $96.07 | n/a | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23.46 → $19.32 | $17.39 | n/a | 5 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.38 | n/a | 5 | Jul 9, 2024 |
CorMedix
May 15, 2026
Maintained: Buy
Price Target: n/a
Current: $8.18
Upside: -
Collegium Pharmaceutical
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $23.37
Upside: -
ANI Pharmaceuticals
May 11, 2026
Maintained: Hold
Price Target: n/a
Current: $70.23
Upside: -
Viatris
May 8, 2026
Reiterated: Buy
Price Target: $20
Current: $16.61
Upside: +20.41%
Vanda Pharmaceuticals
May 7, 2026
Maintained: Buy
Price Target: $18
Current: $5.33
Upside: +237.71%
Pacira BioSciences
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $25.87
Upside: -
Bausch Health Companies Inc.
May 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $8.86
Upside: -
Teva Pharmaceutical Industries
Apr 30, 2026
Rated: Buy
Price Target: $42 → $45
Current: $36.76
Upside: +22.42%
Amneal Pharmaceuticals
Apr 23, 2026
Maintained: Buy
Price Target: n/a
Current: $17.05
Upside: -
biote
Apr 16, 2026
Maintained: Buy
Price Target: $5 → $4
Current: $1.51
Upside: +164.90%
May 27, 2025
Initiated Coverage: Buy
Price Target: €22.00
Current: €22.60
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: n/a
Current: $96.07
Upside: n/a
Jul 26, 2024
Maintained: Buy
Price Target: $23.46 → $19.32
Current: $17.39
Upside: n/a
Jul 9, 2024
Rated: Hold
Price Target: n/a
Current: $3.38
Upside: n/a